Decatur Health & Rehab Center | |
2326 Morgan Avenue Southwest, Decatur, Alabama 35603 | |
(256) 340-5765 | |
Name | Decatur Health & Rehab Center |
---|---|
Location | 2326 Morgan Avenue Southwest, Decatur, Alabama |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 119 |
Occupancy Rate | 52.35% |
Medicare ID (CCN) | 015206 |
Legal Business Name | Usa Healthcare Morgan Llc |
Ownership Type | For Profit - Limited Liability Company |
NPI Number | 1184346561 |
Organization Name | DECATUR SNF OPERATIONS LLC |
Address | 2326 Morgan Ave Sw, Decatur, AL 35601 |
Phone Number | 256-340-5765 |
News Archive
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
A longitudinal study of children of parents with bipolar disorder gives insights into the developmental trajectory of the condition, which researchers say should prove valuable in guiding future intervention and prevention efforts.
MorphoSys AG and US-based biopharmaceutical company Xencor, Inc., announced today the signing of a worldwide exclusive license and collaboration agreement for an antibody in Phase 1 clinical development. The agreement provides MorphoSys with an exclusive worldwide license to XmAb5574, a high potency monoclonal antibody developed by Xencor for the treatment of B-cell malignancies.
The association between long-term smoking and diminished mental proficiency in 172 alcoholic and non-alcoholic men was a surprising finding from a study that set out to examine alcoholism's long-term effect on the brain and thinking skills.
Tests of healthy preterm infants younger than 12 weeks of age show prematurity to be independently associated with reduced lung function. Predictors of this reduced expiratory flow during the first months of life include male sex, low gestational age and increased weight gain.
› Verified 4 days ago
NPI Number | 1568468833 |
Organization Name | USA HEALTHCARE MORGAN LLC |
Doing Business As | DECATUR HEALTH AND REHAB CENTER |
Address | 2326 Morgan Ave Sw, Decatur, AL 35601 |
Phone Number | 256-340-5745 |
News Archive
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
A longitudinal study of children of parents with bipolar disorder gives insights into the developmental trajectory of the condition, which researchers say should prove valuable in guiding future intervention and prevention efforts.
MorphoSys AG and US-based biopharmaceutical company Xencor, Inc., announced today the signing of a worldwide exclusive license and collaboration agreement for an antibody in Phase 1 clinical development. The agreement provides MorphoSys with an exclusive worldwide license to XmAb5574, a high potency monoclonal antibody developed by Xencor for the treatment of B-cell malignancies.
The association between long-term smoking and diminished mental proficiency in 172 alcoholic and non-alcoholic men was a surprising finding from a study that set out to examine alcoholism's long-term effect on the brain and thinking skills.
Tests of healthy preterm infants younger than 12 weeks of age show prematurity to be independently associated with reduced lung function. Predictors of this reduced expiratory flow during the first months of life include male sex, low gestational age and increased weight gain.
› Verified 4 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
A longitudinal study of children of parents with bipolar disorder gives insights into the developmental trajectory of the condition, which researchers say should prove valuable in guiding future intervention and prevention efforts.
MorphoSys AG and US-based biopharmaceutical company Xencor, Inc., announced today the signing of a worldwide exclusive license and collaboration agreement for an antibody in Phase 1 clinical development. The agreement provides MorphoSys with an exclusive worldwide license to XmAb5574, a high potency monoclonal antibody developed by Xencor for the treatment of B-cell malignancies.
The association between long-term smoking and diminished mental proficiency in 172 alcoholic and non-alcoholic men was a surprising finding from a study that set out to examine alcoholism's long-term effect on the brain and thinking skills.
Tests of healthy preterm infants younger than 12 weeks of age show prematurity to be independently associated with reduced lung function. Predictors of this reduced expiratory flow during the first months of life include male sex, low gestational age and increased weight gain.
› Verified 4 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 0 |
Total Amount of Fines in Dollars | $0 |
Number of Payment Denials | 0 |
Total Number of Penalties | 0 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 15.49 | 14.46 |
Percentage of long-stay residents who lose too much weight | 11.01 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 71.84 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.59 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 4.26 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 2.9 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 11.99 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 1.71 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 17.34 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 16.67 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 3.75 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 95.24 | 95.98 |
Percentage of short-stay residents who made improvements in function | 53.99 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 53.9 | 82.93 |
News Archive
OSI Pharmaceuticals, Inc. will fully redeem on April 21, 2010 all of its remaining outstanding 3.25% Convertible Senior Subordinated Notes due 2023 pursuant to the terms of the indenture under which the Notes were issued in September 2003. The aggregate principal amount currently outstanding of the Notes is $60,467,000. The CUSIP number for these Notes is 671040 AD 5.
A longitudinal study of children of parents with bipolar disorder gives insights into the developmental trajectory of the condition, which researchers say should prove valuable in guiding future intervention and prevention efforts.
MorphoSys AG and US-based biopharmaceutical company Xencor, Inc., announced today the signing of a worldwide exclusive license and collaboration agreement for an antibody in Phase 1 clinical development. The agreement provides MorphoSys with an exclusive worldwide license to XmAb5574, a high potency monoclonal antibody developed by Xencor for the treatment of B-cell malignancies.
The association between long-term smoking and diminished mental proficiency in 172 alcoholic and non-alcoholic men was a surprising finding from a study that set out to examine alcoholism's long-term effect on the brain and thinking skills.
Tests of healthy preterm infants younger than 12 weeks of age show prematurity to be independently associated with reduced lung function. Predictors of this reduced expiratory flow during the first months of life include male sex, low gestational age and increased weight gain.
› Verified 4 days ago
River City Center Location: 1350 Fourteenth Avenue Southeast, Decatur, Alabama 35601 Phone: (256) 355-6911 | |
Decatur Health & Rehab Center Location: 2326 Morgan Avenue Southwest, Decatur, Alabama 35603 Phone: (256) 340-5765 |